Mid term Flashcards
(137 cards)
1
Q
Examples of drugs that are plant derived
A
digoxin, aspirin, morphine
2
Q
semi synthetic drugs
A
have component of both synthetic and naturally occurring molecule
3
Q
xenobiotics
A
compound that is foreign to the body
4
Q
types of names of drugs
A
chemical name, generic name, brand name
5
Q
5 rights of drug administration
A
right drug, right patient, right dose, right route, right time
6
Q
oral administration
A
most common route; drugs must be metabolized in gut wall or liver prior to reaching circulation (first pass metabolism)
7
Q
first pass metabolism
A
metabolizing of a drug that decreases the amount of active drug absorbed; metabolism of a drug before it reaches systemic circulation (ex: PO and PR); can be metabolized by enzymes in the intestines prior to undergoing further metabolism in liver prior to systemic circulation
8
Q
sublingual administration
A
absorbed under the tongue; lots of vasculature making it a good way to administer medication that needs to enter bloodstream rapidly
9
Q
transdermal administration
A
slow and continuous absorption through the skin
10
Q
interosseous administration
A
injecting into bone marrow; substitute for inability to obtain IV access
11
Q
intramuscular administration
A
delivered into muscle; muscle mass and perfusion can affect how quickly drug is absorbed
12
Q
subcutaneous
A
delivered into subcutaneous fatty tissue directly below skin
13
Q
Intravenous administration
A
fastest route to administer drugs; rapidly distributed
14
Q
intrathecal
A
delivering drugs into spinal cord to reach CNS; released into CSF
15
Q
intraperitoneal
A
peritoneum is semi-permeable and some people on dialysis may receive drugs this way
16
Q
bioavailability
A
rate and extent of absorption; amount that reaches circulation
17
Q
drug chemical/physiochemical properties affecting absorption
A
drug solubility/dissolution rate, size/surface area, polymorphism/amorphism, solvates/hydrates, salt form of drug, ionization stated, pKA/lipophilicity and GI pH
18
Q
drug formulation factors affecting absorption
A
disintegration time, manufacturing variables, nature type and dose, ingredients, product age and storage conditions
19
Q
patient factors that affect drug absorption
A
age, gastric emptying time, intestinal transit time, disease status, blood flow at absorption site, first pass metabolism, GI content (food)
20
Q
pharmacokinetics of medication in body
A
- absorbed into circulation
- distributed to various tissues
- metabolized or broken down
- eliminated/excreted in urine or feces
21
Q
absorption
A
transportation of unmetabolized drug from site of administration to the body circulation system
22
Q
area of the body with the fastest drug absorption
A
duodenal mucosa because of the villi and microvilli which proved large surface area
23
Q
overview of how drugs work
A
bind to a receptor -> activate cascade of intracellular effects -> results in change in cellular function -> cause physiological response of the drug
24
Q
agonist
A
enhances activity; molecule capable of binding to and activating target protein; produce the desired effects by activating receptors
25
example of agonist
fentanyl binds to Mu, kappa, and delta receptors of CNS and PNS, activating them to produce desired affects such as analgesia and euphoria
26
antagonist
molecule that binds to target and prevents other molecules from binding to active receptor site
27
example of antagonist
atropine which is an antimuscarinic agent blocks muscarinic receptors of heart reversing vagally stimulated bradycardia
28
what happens when there is repeated receptor activation of a drug
desensitization of receptor response; decreased efficacy of drug
29
efficacy of a drug
extent that a drug can produce a response when all receptors/binding sites are occupied
30
potency of a drug
amount of drug necessary to produce an effect (more potent requires lower dosage)
31
therapeutic index
ratio of the drug that produces toxicity in half of the population to the dose that produces clinically desired response in half the population
32
as molecular weight approaches 500 daltons
skin permeation approaches zero
33
chiral atoms
carbon atom connected to 4 different substituents; creates asymmetric carbon atom that is not superimposable
34
R enantiomer of albuterol
right handed; creates the bronchodilation effect of when interacting with beta receptor
35
S enantiomer of albuterol
left handed; blocks metabolic pathways of R enantiomer and has slower rate of elimination causing accumulation in lungs = hyperreactivity and inflammation
36
polypharmacy
regular use of at least 5 medications
37
BEERS criteria
1. reduce older adults exposure to potentially inappropriate medications; 2. educate clinicians and patients; 3. serve as tool for quality of care, cost, and patterns of drug use in older adults
38
pharmacokinetics
what the body does to a drug
39
phamarcodynamics
what the drug does to the body
40
distribution of drug depends on
blood flow, capillary permeability, binding of drugs to plasma proteins, binding of drugs to tissues, lipophilicity, volume of distribution
41
main source of drug metabolism
liver due to the enzymes present
42
how drugs can be metabolized
oxidation, reduction, hydrolysis, hydration, conjugation, condensation, isomerization
43
reasons for increased half life in indviduals
decreased renal/hepatic blood flow, decreased extracting of drug from plasma, decreased metabolism (ex: liver cirrhosis)
44
first order kinetics
rate of elimination is proportional to drug concentration; more drug = faster metabolism
45
zero order kinetics
rate of elimination is constant
46
examples of zero order kinetics
warfarin, heparin, aspirin, alcohol, theophylline, tolbutamide, phenytoin, phenylbutazone, ethanol
47
purpose of drug metabolism
make drug more hydrophilic and more water soluble to facilitate elimination
48
drug metabolized from and to
1. toxic drug to nontoxic metabolite; 2. prodrug to an active drug; 3. active drug to inactive drug
49
phase 1 metabolism
oxidation, reduction, and hydrolysis reactions that converts drug to more polar molecule or converts lipid soluble to water soluble
50
most important enzyme in phase 1 metabolism
CYP450
51
CYP450
microsomal superfamily of isoenzymes that catalyzes oxidation of many drugs; can be induced or inhibited
52
phase 2 metabolism
conversion of parent drug to more polar (water soluble) inactive metabolites; renally excreted
53
CYP450 components
CYP3A4 and CYP206 which metabolize 50% and 25% of drugs
54
glomerular filtration
drugs enter kidney through renal arteries and divide to form glomerular capillary
55
proximal tubular secretion
represents primary kidney mechanism for eliminating hundreds of commonly prescribed meds
56
distal tubular reabsoprtion
passive process where drugs are reabsorbed into systemic circulation from lumen of distal tubules
57
normal glomerular filtration rate
120mL/min/1.73m3
58
pain
unpleasant sensory and emotional experience associated with actual or potential tissue damage
59
nocioceptive pain
to minimize and avoid damage from intense noxious stimuli; immediate attention and withdrawal
60
inflammatory pain
low threshold pain; tenderness discourages contact and movement reducing further risk of injury and promoting healing
61
neuropathic pain
lesion or disease of somatosensory nervous system; low threshold
62
CNS dysfunctional pain
no damage or inflammation; low threshold
63
pain therapies to close gate
massage, acupuncture, electrotherapy (surface nerve stim)
64
non-opioid analgesics
acetaminophen, ibuprofen, aspirin, anticonvulsants, antidepressants, topical agents, other NSAIDs
65
acetaminophen mechanism of action
interaction of cyclooxygenase and cyclooxygenase receptor pathway; acts on CNS cox receptors to block them and decrease prostaglandin synthesis = analgesic effect
66
acetaminophen mechanism of action (other way)
stimulates descending serotonergic pathway which regulates pain
67
acetaminophen dosage
pediatrics = weight based
adults = 325-975 (max 4g in 24 hours)
68
acetaminophen onset
30-60 minutes oral
5-10 minutes IV
peaks in about 4 hours
69
acetaminophen metabolism
undergoes both phase 1 and phase 2
70
primary metabolic pathway of acetaminophen
sulfation and glucuronidation leading to more water soluble metabolite to be excreted renally
71
rest of metabolic pathway of acetaminophen
metabolized by cytochrome P450 system to N-acetyl-p-benzoquinomine (toxic metabolite) which can bind to liver cells and cause injury; quickly bound to tripeptide glutathione inactivating metabolite and becoming more water soluble to be excreted renally
72
NSAID mechanism of action
works primarily on cyclooxygenase receptor
73
NSAID with PPI
reduce GI affects by decreasing overall stomach pH as method to reduce risk of gastritis and GI bleeding
74
gabapentin
anti-convulsant med that inhibits release of excitatory neurotransmitters; excreted unchanged through kidneys; used for seizure and neuropathic pain
75
pregabalin
inhibits excitatory neurotransmitter release, focal onset seizures, diabetic neuropathy, herpetic neuralgia, and fibromyalgia
76
amitriptyline
tricyclic antidepressant (TCA); inhibits norepi and serotonin reuptake into presynaptic neuron; prevents migraines headache and chronic pain
77
duloxetine
inhibits serotonin and norepi reuptake (SNRI); only metabolized in liver; GI side effects; moderate inhibitor of CYP3A4
78
opioids work how?
bind to specific receptors in CNS to produce effects that mimic action of endogenous peptide neurotransmitters
79
receptor families
1. Mu (MOP)
2. Kappa (KOP)
3. Delta (DOP)
4. Nociceptin (NOP)
80
naturally occurring compounds
morphine, codeine, thebaine, papaverine
81
semi-synthetic compounds
diamorphine (heroin), dihydromorphone, buprenorphine, oxycodone
82
synthetic compounds
pethidine, fentanyl, methadone, alfentanil, remifentanil, tapentadol
83
morphine mechanism of action
analgesic affect d/t sterospecific interaction with opioid receptors on membranes of neuronal cells on CNS
84
morphine actions
analgesia, euphoria, respiratory depression, cough reflex depression, miosis, emesis,
85
morphine
hydrophilic, metabolizes through conjug. in liver and p-glycoprotein, active metabolites renally eliminated, abuse deterrent formulas available
86
methadone
no active metabolites, racemic mix., metabolized by CYP450, lipophilic, can prolong QTC interval and cause torsades de pointes
87
fentanyl
100x more potent than morphine, greater lipophilicity and CNS penetration than morphine, metabolized by CYP3A4, no active metabolites
88
oxycodone
active metabolite is noroxycodone; metabolized by CYP2D6 and CYP3A4;less histamine and nausea; abuse deterrent fomulation available
89
oxymorphone
longer duration of immediate release than other opioids; oral bioavailability increases with food and alcohol; administered 1-2 hours after eating
90
hydromorphone
greater lipophilicity and CNS penetration than morphine; metabolized glucoronidation to H6G and H3G (renally excreted); abuse deterrent
91
codeine
prodrug; metabolized by CYP2D6 to active drug morphine; moderate to mild pain use; not for renally impaired, children under 12, children tonsils removal, obese w/ sleep apnea
92
hydrocodone
active metabolite is hydromorphone; metabolized by CYP2D6 and CYP3A4; abuse deterrent available
93
meperidine
not firs choice; active metabolite normeperidine which can accumulate with renal impairment = toxicity; naloxone does not work and can worsen seizure activity; dont use in elderly, liver/renal impairment, or chronic pain manage
94
tapentadol
Mu agonist and norepi reuptake inhibiter, treats nociceptive and neuropathic pain; metabolized by glucuronidation ; no CYP450 interact
95
tramadol
metabolized by phase 1 and 2 with CYP2D6, CYP2B6, CYP3A4
96
BUPRENORPHINE
mixed agonist-antagonist; partial agonist at mu and ORL-1 receptor, antagonist at kappa and delta receptor; long duration (very lipophilic); abuse deterrent available;
97
BUPRENORPHINE and naloxone
incompletely reversed
98
NALOXONE
antagonist at mu, kappa, and delta receptor (10x affinity for mu than kappa); half life 30-90 min; oral not effective
99
naltrexone
antagonist; similar to naloxone but longer duration (blocks effects of heroin 24 hrs-30 days); oral or injection
100
Benzodiazepines uses
CNS depressant, anxiolytic, hypnotic, anticonvulsant, amnesia, muscle spasm, withdrawal
101
benzodiazepine structure
central carboxamide group 7 membered heterocyclic ring w/ halogen or nitrogen (7th pos.)
102
Benzo receptor interaction
act at GABA (a specifically) allosterically causing increased action of GABA receptor
103
GABA receptor action
opens and allows Cl- ions in (hyperpolarizing) making neuron less likely to fire; results in calming effects
104
benzo metabolism
highly lipophilic = longer metabolize (need to become more water-soluble); majority of metabolism liver and CYP450
105
adverse side effects of benzos
dependence in high doses; drowsiness, confusion, ataxia, EtOH and of CNS depressants enhance, opioid use w/ benzo = sedation and resp. depress.
106
barbituates
used for alcohol withdrawal and seizure management; mainly replaced by benzos; no analgesic/may exacerbate pain
107
why were barbituates replaced
tolerance and physical dependence, lethal in OD, severe withdrawal
108
long acting barbituate
phenobarbital (> 1day)
109
short acting barbituate
pentobarbital (1-2 hours), secobarbital, amobarbital
110
low does barbituate effect
sedation, calming effect, reduce excitement
111
high dose barbituate
hypnosis, anesthesia, coma/death
112
barbituate receptor interaction
low doses enhance GABA and open Cl- channel for longer; high dose open GABA without GABA present; can block glutamate receptor
113
glutamate
excitatory neurotransmitter
114
barbituate metabolism
liver and CYP450; half-life 100-140 hours
115
anticonvulsant drug types
sodium channel blockers (carbamazepine), Ca blockers (depakote), unknown (keppra, gabapentin)
116
topiramate
anticonvulsant that decreases effects of oral contraceptives
117
CYP450 Induction
increase rate of hepatic metabolism
118
CYP450 inhibitor
block metabolic activity
119
stevens-johnson syndrome
disorder of skin and mucous membranes; usually reaction that resembles flu-like symptoms; painful rash/blisters where top layer dies and sheds; toxic epidermal necrolysis
120
antidepressants
used to treat depression by potentiating effects of norepinephrine or serotonin
121
norepinephrine
neurotransmitter and hormone; increases alertness, arousal, attention, constricts blood vessels, affects sleep wake cycle, mood, and memory
122
serotonin
monoamine neurotransmitter that acts as hormone, influences learning and happiness, regulates body temp., sleep, sexual behavior, hunger
123
90% of serotonin found where
GI tract cells
124
decreased serotonin
thought to cause anxiety and depression (mania sometimes)
125
types of antidepressants
monoamine oxidase inhibitors, tricyclic, tetracyclic and unicyclic, SARI's, SSRI's, SNRI's
126
serotonin syndrome
life threateining condition from use of serotonergic drugs; AMS, autonomic hyperactivity, neuromuscular abnormalities
127
baclofen
antispasmotic that distributes to brain and spinal cord to cause muscle relaxation
128
oral baclofen
70-85% bioavailability; excreted by kidneys mainly; half-life of 3 hours; brain and spinal cord
129
intrathecal baclofen
allows for greater concentrations in spinal cord with lower levels in brain; half-life is about 5 hours
130
baclofen receptor interaction
agonist of GABA B (only one available)
131
GABA B
present in brain, ventral and dorsal horns, outside BBB, within sympathetic nervous system, some visceral tissues
132
why use baclofen
spasms due to MS, TBI, spinal cord injury or lesions
133
baclofen toxicity
hypothermia, bradycardia, hypotension, excess. saliv., HTN, tachycardia, depressed mental status, coma, seizures, resp. supress., N/V
134
migraine preventative drugs
beta-blockers (metoprolol), anti-epilectics (topiramate), tricyclic antidepressants (amitriptyline)
135
migraine abortive agents
ergot, triptans, ditans, calcitonin gene-related peptide (CGRP) receptor antagonists
136
why no triptan use with history of MI
side effects can mimic MI which could hide real MI symptoms
137
volume of distribution
